JAK Signaling Is Critically Important in Cytokine-Induced Viral Susceptibility of Keratinocytes

Kimberly A Arnold1, Liam F Peterson2, Lisa A Beck1,2

  • 1Departments of Dermatology, University of Rochester Medical Center, Rochester, NY 14642, USA.

Insights

Certain immune signaling proteins, like IL-4/IL-13 and IL-22, increase skin cell susceptibility to viruses, while IFNγ offers protection. Janus kinase inhibitors (JAKi) can modulate these effects.

Area of Science:

  • Immunology
  • Dermatology
  • Virology

Background:

  • Keratinocytes (KC) are crucial for skin immunity and barrier function.
  • Type 1 (interferon-gamma, IFNγ), type 2 (interleukin-4/13, IL-4/IL-13), and type 3 (IL-17A/IL-22) cytokines are implicated in skin diseases like atopic dermatitis, psoriasis, and lupus.
  • Janus kinase inhibitors (JAKi) are therapeutic agents for these conditions.

Purpose of the Study:

  • To investigate how type 1, 2, and 3 cytokines affect keratinocyte susceptibility to viral infections.
  • To determine if JAK inhibitors can modulate cytokine-induced changes in viral susceptibility in keratinocytes.

Main Methods:

  • Immortalized and primary human keratinocytes were pretreated with specific cytokines (IFNγ, IL-4/IL-13, IL-22).
  • Cells were subsequently infected with vaccinia virus (VV) or herpes simplex virus-1 (HSV-1).
  • The effect of JAK inhibitors (targeting JAK1, TYK2, or JAK2) on viral infection was assessed.

Main Results:

  • Type 2 (IL-4 + IL-13) and type 3 (IL-22) cytokines significantly increased keratinocyte susceptibility to VV infection.
  • IFNγ significantly reduced keratinocyte susceptibility to VV infection.
  • JAK1 inhibition reversed IL-4/IL-13-induced susceptibility, TYK2 inhibition reversed IL-22-induced susceptibility, and JAK2 inhibition reversed IFNγ-mediated protection.

Conclusions:

  • Cytokines prevalent in atopic dermatitis skin (IL-4, IL-13, IL-22) enhance keratinocyte viral susceptibility.
  • IFNγ exhibits a protective effect against viral infection in keratinocytes.
  • JAK inhibitors demonstrate potential in modulating these cytokine-driven changes in viral susceptibility, offering therapeutic insights for skin diseases.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K